Date: Monday, March 12
Time: 6:30 – 8:30 p.m.
Place: Metcalf Research Building, Pilch Friedman Auditorium, 190 Thayer St, Providence RI (directions)
Open to: All (recommended for adults and seniors)
GeneMatch swab space is limited – Please register!
Could your genes help end Alzheimer’s disease? Let’s find out! Join us for a community presentation and registration event to learn more about Alzheimer’s disease prevention studies. The informational session will discuss the latest in prevention research and clinical trial opportunities that are available at Butler’s Memory and Aging Program.
We will also discuss GeneMatch, a program that has been developed by the Alzheimer’s Prevention Initiative for individuals aged 55-75 years with normal memory and thinking abilities who may be interested in participating in Alzheimer’s research studies based in part on their APOE genetic information.
How does GeneMatch work?
- GeneMatch will provide interested individuals (first come first served – swabs limited) at the session with a cheek swab kit to determine which copies of the APOE gene you have.
- All interested participants will need to refrain from eating or drinking anything other than water within one hour before collecting the cheek swab.
- You will not be told your APOE results as part of the GeneMatch Program. GeneMatch will add you to its secure database and may contact you about study opportunities that may ask you to learn your APOE results. Whether or not you decide to participate in these study opportunities is entirely up to you.
- You will need to provide an email address to participate in GeneMatch.
Stephen Salloway, MD, MS: Dr. Salloway received his MD from Stanford Medical School and completed residencies in neurology and psychiatry at Yale University. He is Chief of Neurology and Director of the Memory and Aging Program at Butler Hospital and Professor of Neurology and Psychiatry at the Alpert Medical School of Brown University.
Dr. Salloway is an internationally recognized leader in clinical trials for the prevention and treatment of Alzheimer’s disease. During his 26 years at Brown his program has conducted more than 100 clinical trials for Alzheimer’s and related disorders. He has served as a lead author for key publications in Alzheimer’s research in the New England Journal of Medicine, Nature and other top-tiered journals. The Butler memory team is developing innovative approaches for involving the public in Alzheimer’s prevention.